Tag: Gilead
Gilead won a valuable FDA voucher with its Veklury approval, but...
Gilead Sciences has the most successful COVID-19 drug so far in Veklury, an antiviral also known as remdesivir that was originally developed through research programs into hepatitis C and respiratory syncytial virus....
COVID-19 fighter remdesivir racks up $873M as Gilead plays defense on...
Gilead Sciences started charging for remdesivir in July. Given its status then as the only drug authorized for COVID-19 in the U.S., industry watchers...
Gilead Sciences adds 140 jobs as it looks to expand its...
Gilead Sciences has been slowly growing its operations in Ireland, a biopharma hotspot, to help distribution of its blockbuster HIV meds. Now, the California...
Remdesivir stockpiling could help push COVID drug into profitable territory for...
Ever since the FDA last month cleared Gilead’s remdesivir for emergency use to treat COVID-19, investors have been wondering if the drug could possibly...
Gilead fails to overturn $752M CAR-T patent verdict. Will BMS win...
Bristol Myers Squibb and Gilead Sciences have been locked in a CAR-T patent fight, with BMS scoring a lucrative victory following a trial late last year. Now,...
